Literature DB >> 21270792

Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics.

K A Perkins1, C Lerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21270792      PMCID： PMC3188428          DOI： 10.1038/clpt.2010.254

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  28 in total

Review 1.  Medication screening for smoking cessation: a proposal for new methodologies.

Authors:  Kenneth A Perkins; Maxine Stitzer; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2005-09-15       Impact factor: 4.530

Review 2.  Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors:  Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

3.  Optimal adaptive design in clinical drug development: a simulation example.

Authors:  Alan Maloney; Mats O Karlsson; Ulrika S H Simonsson
Journal:  J Clin Pharmacol       Date:  2007-10       Impact factor: 3.126

Review 4.  Alternatives to placebo-controlled trials.

Authors:  David L Streiner
Journal:  Can J Neurol Sci       Date:  2007-03       Impact factor: 2.104

Review 5.  Translational research in medication development for nicotine dependence.

Authors:  Caryn Lerman; Mark G LeSage; Kenneth A Perkins; Stephanie S O'Malley; Steven J Siegel; Neal L Benowitz; William A Corrigall
Journal:  Nat Rev Drug Discov       Date:  2007-09       Impact factor: 84.694

6.  The state of innovation in drug development.

Authors:  I Kola
Journal:  Clin Pharmacol Ther       Date:  2008-02       Impact factor: 6.875

7.  Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials.

Authors:  Sue-Jane Wang; Robert T O'Neill; Hm James Hung
Journal:  Clin Trials       Date:  2010-07-01       Impact factor: 2.486

Review 8.  Crossover studies: a modified analysis with more power.

Authors:  T J Cleophas
Journal:  Clin Pharmacol Ther       Date:  1993-05       Impact factor: 6.875

9.  The effect of bupropion on nicotine craving and withdrawal.

Authors:  S Shiffman; J A Johnston; M Khayrallah; C A Elash; C J Gwaltney; J A Paty; M Gnys; G Evoniuk; J DeVeaugh-Geiss
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

10.  The Biomarkers Consortium: on the critical path of drug discovery.

Authors:  C A Altar
Journal:  Clin Pharmacol Ther       Date:  2008-01-09       Impact factor: 6.875
View more
  6 in total

1.  The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.

Authors:  Meghan J Chenoweth; Robert A Schnoll; Maria Novalen; Larry W Hawk; Tony P George; Paul M Cinciripini; Caryn Lerman; Rachel F Tyndale
Journal:  Nicotine Tob Res       Date:  2015-06-11       Impact factor: 4.244

Review 2.  An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.

Authors:  Kenneth A Perkins; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2013-12-03       Impact factor: 4.530

3.  Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications.

Authors:  Kenneth A Perkins; Caryn Lerman; Joshua L Karelitz; Nancy C Jao; K N Roy Chengappa; Garrett M Sparks
Journal:  Addiction       Date:  2013-07-12       Impact factor: 6.526

4.  The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence.

Authors:  Rebecca L Ashare; E Paul Wileyto; Kenneth A Perkins; Robert A Schnoll
Journal:  J Addict Med       Date:  2013 Jul-Aug       Impact factor: 3.702

5.  Withdrawal-Related Changes in Delay Discounting Predict Short-Term Smoking Abstinence.

Authors:  Rickie Miglin; Joseph W Kable; Maureen E Bowers; Rebecca L Ashare
Journal:  Nicotine Tob Res       Date:  2017-06-01       Impact factor: 4.244

6.  Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.

Authors:  Christian S Hendershot; Jeffrey D Wardell; Andriy V Samokhvalov; Jürgen Rehm
Journal:  Addict Biol       Date:  2016-07-14       Impact factor: 4.280
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.